Professional Documents
Culture Documents
Module 3: Labelling
Time Frame: Week 7 & 8 (8hours)
Schedule of synchronous sessions:
Mapped Learning Outcomes and Course Content for C-PPD1 Dispensing 1, Module 3
Target Learning Outcomes Content and Activities
Hour (At the close of the period allotted, Online Session Offline Session
students should have :)
8 hours Determining the Interactive lecture: Worksheets Activity for Laboratory
information on the drug Labelling Written Report#3: Pharmaceutical
label required by FDA. Labelling
Preparing a label of unit -Definition of Terms
dose, reconstituted, -Pharmaceutical
external and sterile Labelling
compounding preparation. -General Guidelines
for Labelling
Requirements
Definition of Terms
◉ Dispensing refers to the sum of processes performed by a pharmacist from reading, validating, and
interpreting prescriptions; preparing; packaging; labeling; record keeping; dose calculations; and
counseling or giving information, in relation to the sale or transfer of pharmaceutical products, with
or without a prescription or medication order
◉ Label refers to a display of written, printed, or graphic matter on the immediate container of any
article;
◉ Labeling materials refer to all labels and other written, printed, or graphic matter: (1) upon any
item or any of its containers or wrappers; or (2) accompanying any such an article.
Sec. 36 of RA 10918
Label of Dispensed Medicines
◉ the name of patient
◉ generic name of drug;
◉ brand name, if any,
◉ strength,
◉ expiry date,
◉ directions for use;
◉ name and address of pharmacy,
◉ name of the doctor,
◉ name of the dispensing pharmacist
◉ Other requirements*
◉ Auxiliary labels containing special pharmacists' instructions for the patient shall be required as
prescribed for dangerous drugs,
◉ External-use-only drugs, drugs with special storage and administration instructions and such other
drugs as may be required by law
A.O. 2016-0008 Revised Rules and Regulations Governing the Generic Labelling Requirements of
Drug Products for Human Use
GENERAL GUIDELINES
◉ The following are the minimum mandatory information that shall appear in the labeling materials
accompanying a drug product:
(a) Product Name
(b) Dosage Form and Strength
(c) Pharmacologic Category
(d) Formulation/Composition
(e) Indication(s)
(f) Dosage and Mode of Administration
(g) Contraindication(s), Precaution(s), Warning(s) (if applicable)
(h) Interactions
(i) Adverse Drug Reaction(s)
PHARMACEUTICAL LABELLING
LABEL
“ Label means a display of written, printed or graphic matter upon immediate container or the wrapper of a
drug package”
TYPES OF LABEL
•
Manufacturer label
•
Dispensing label
Manufacturer label
• A label which contain drug information for the use of medical practitioners, pharmacists, or nurses
supplied by the manufacturer, packer, or distributor of the drug (FDA)
Brand Name:
•
Brand name which is used to market the drug
•
Property of drug company
STRENGTH
• It is amount of active drug per unit dose.
• Example: amoxicillin 250mg capsules and amoxicillin 500mg capsules.
SPECIFICATION
•
U.S.P
•
B.P
DOSAGE FORM
• Dosage form of the medicine should be mentioned on the label. e.g.,
• Different dosage forms of Amoxicillin
QUANTITY
Quantity /volume present per a packaging unit
INSTRUCTIONS
Warning!!!!!
DO NOT SHAKE THE PATIENT,
SHAKE THE BOTTLE WELL BEFORE USE…….
Precautions
Storage conditions
Store in a cool place:
1. Not more than 0˚C-8˚C is necessary for many products
Inflammable:
If the preparation contain 50% or more alcohol or any other inflammable solvent, the label should contain
word inflammable
Not to be taken:
◉ Liquid preparation that are not administered by mouth
◉ For nasal drops, enemas and nasal sprays
◉ Unit dosage forms e.g., pessaries and rectal suppositories
◉ Help to administer drugs safely
Types of warnings
If hypersensitivity to a drug
•
For controlled substances
•
About combining with other drugs or products
Registration number
•
“A number given to a specific drug when it is registered according to specific rules by registration board set
up by federal government”
Batch number
•
“A designation printed on label of a drug that identifies the batch and permits the production history of the
batch including all stages of manufacturer and control to be traced and are viewed”
Manufacturing date
Expiry date
•
“Date stated on the label of a drug after which a drug is not expected to retain its claimed efficacy, safety,
quantity, or potency or after which it is no permissible to sell the drug”
License number
•
Biological products are approved for marketing under the provisions of the Public Health Service (PHS) Act.
The Act requires a firm who manufactures a biologic for sale in interstate commerce to hold a license for the
product
Manufacturer information
•
Name
•
Address
Price
Barcodes
•
“It is an optical machine readable representation of data, which shows data about the object to which it
attaches”
DISPENSING LABEL
It includes:
•
Drug name and quantity
•
Patient name
•
Prescription number
•
Phone number
•
Instruction for use
•
Pharmacy name and address
SPECIAL INSTRUCTIONS
Includes the information about:
1. Directions for use:
◉ How to take a medicine
EAR DROPS
•
For external use only
AEROSOLS INHALATIONS
•
Pressurized containers keep away from heat source
•
Shake before use
•
Do not exceed the prescribed dose
CREAMS
•
For external use only
•
Store in cool place
Interactions
• Certain drugs may have serious reactions if eat with particular food or drugs,e.g:
a) Amine containing foods (tyrosine) with monoamine oxidase inhibitors.(hypertension crises)
b) Tetracycline with milk
LABORATORY WORKSHEET
2. Evaluation of Learning
For the evaluation of learning for Module 3, a scheduled quiz will be assigned in the Google Classroom and
will be taken before the start of the next Module during the Synchronous Class.
References
Adams, C.H. and Jones, P.D. Therapeutic communication for health professionals (2011/latest edition)
Pharmacists talking with patients: a guide to patient counseling / Melanie J. Rantucci. (2012)
Congratulations for having completed this C-PPD1 Module 3! See you in the next Module